Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 4-hydroxy-3-phenylbutyric Acid Sodium Salt
2. Sodium 4-hydroxy-3-phenylbutanoate
3. 4zy84kzd7g
4. 40951-19-7
5. Beta-phenyl-gamma-oxybutyrate Sodium
6. Gamma-hydroxy-beta-phenylbutyrate Sodium
7. Butyric Acid, 4-hydroxy-3-phenyl-, Sodium Salt
8. Srisec127
9. Unii-4zy84kzd7g
10. Schembl14698168
11. Dtxsid40961323
12. F72098
13. Sodium .beta.-phenyl-.gamma.-hydroxybutyrate
14. Q27260724
15. Benzenepropanoic Acid, .beta.-(hydroxymethyl)-, Sodium Salt (1:1)
| Molecular Weight | 202.18 g/mol |
|---|---|
| Molecular Formula | C10H11NaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 202.06058849 g/mol |
| Monoisotopic Mass | 202.06058849 g/mol |
| Topological Polar Surface Area | 60.4 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 167 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
35
PharmaCompass offers a list of Sodium 4-Hydroxy-3-Phenylbutanoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium 4-Hydroxy-3-Phenylbutanoate manufacturer or Sodium 4-Hydroxy-3-Phenylbutanoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium 4-Hydroxy-3-Phenylbutanoate manufacturer or Sodium 4-Hydroxy-3-Phenylbutanoate supplier.
PharmaCompass also assists you with knowing the Sodium 4-Hydroxy-3-Phenylbutanoate API Price utilized in the formulation of products. Sodium 4-Hydroxy-3-Phenylbutanoate API Price is not always fixed or binding as the Sodium 4-Hydroxy-3-Phenylbutanoate Price is obtained through a variety of data sources. The Sodium 4-Hydroxy-3-Phenylbutanoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A beta-Phenyl-gamma-oxybutyrate sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of beta-Phenyl-gamma-oxybutyrate sodium, including repackagers and relabelers. The FDA regulates beta-Phenyl-gamma-oxybutyrate sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. beta-Phenyl-gamma-oxybutyrate sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A beta-Phenyl-gamma-oxybutyrate sodium supplier is an individual or a company that provides beta-Phenyl-gamma-oxybutyrate sodium active pharmaceutical ingredient (API) or beta-Phenyl-gamma-oxybutyrate sodium finished formulations upon request. The beta-Phenyl-gamma-oxybutyrate sodium suppliers may include beta-Phenyl-gamma-oxybutyrate sodium API manufacturers, exporters, distributors and traders.
click here to find a list of beta-Phenyl-gamma-oxybutyrate sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A beta-Phenyl-gamma-oxybutyrate sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of beta-Phenyl-gamma-oxybutyrate sodium active pharmaceutical ingredient (API) in detail. Different forms of beta-Phenyl-gamma-oxybutyrate sodium DMFs exist exist since differing nations have different regulations, such as beta-Phenyl-gamma-oxybutyrate sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A beta-Phenyl-gamma-oxybutyrate sodium DMF submitted to regulatory agencies in the US is known as a USDMF. beta-Phenyl-gamma-oxybutyrate sodium USDMF includes data on beta-Phenyl-gamma-oxybutyrate sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The beta-Phenyl-gamma-oxybutyrate sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of beta-Phenyl-gamma-oxybutyrate sodium suppliers with USDMF on PharmaCompass.
beta-Phenyl-gamma-oxybutyrate sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of beta-Phenyl-gamma-oxybutyrate sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right beta-Phenyl-gamma-oxybutyrate sodium GMP manufacturer or beta-Phenyl-gamma-oxybutyrate sodium GMP API supplier for your needs.
A beta-Phenyl-gamma-oxybutyrate sodium CoA (Certificate of Analysis) is a formal document that attests to beta-Phenyl-gamma-oxybutyrate sodium's compliance with beta-Phenyl-gamma-oxybutyrate sodium specifications and serves as a tool for batch-level quality control.
beta-Phenyl-gamma-oxybutyrate sodium CoA mostly includes findings from lab analyses of a specific batch. For each beta-Phenyl-gamma-oxybutyrate sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
beta-Phenyl-gamma-oxybutyrate sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (beta-Phenyl-gamma-oxybutyrate sodium EP), beta-Phenyl-gamma-oxybutyrate sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (beta-Phenyl-gamma-oxybutyrate sodium USP).